BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gelincik A, Brockow K, Çelik GE, Doña I, Mayorga C, Romano A, Soyer Ö, Atanaskovic-Markovic M, Barbaud A, Torres MJ. Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper. Allergy 2020;75:2775-93. [PMID: 32511784 DOI: 10.1111/all.14439] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Farajzadeh S, Ahramiyanpour N. Which immunosuppressive drug is preferred in the treatment of toxic epidermal necrolysis during COVID-19 outbreak? Clin Case Rep 2021;9:e04249. [PMID: 34026201 DOI: 10.1002/ccr3.4249] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ding M, Dong X, Sun YL, Sokolowska M, Akdis M, van de Veen W, Azkur AK, Azkur D, Akdis CA, Gao YD. Recent advances and developments in COVID-19 in the context of allergic diseases. Clin Transl Allergy 2021;11:e12065. [PMID: 34582102 DOI: 10.1002/clt2.12065] [Reference Citation Analysis]
3 Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M, Alves-Correia M, Antó JM, Arcolaci A, Azkur AK, Azkur D, Beken B, Boccabella C, Bousquet J, Breiteneder H, Carvalho D, De Las Vecillas L, Diamant Z, Eguiluz-Gracia I, Eiwegger T, Eyerich S, Fokkens W, Gao YD, Hannachi F, Johnston SL, Jutel M, Karavelia A, Klimek L, Moya B, Nadeau KC, O'Hehir R, O'Mahony L, Pfaar O, Sanak M, Schwarze J, Sokolowska M, Torres MJ, van de Veen W, van Zelm MC, Wang Y, Zhang L, Jiménez-Saiz R, Akdis CA. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy 2020;75:2503-41. [PMID: 32535955 DOI: 10.1111/all.14449] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 30.5] [Reference Citation Analysis]
4 Gao YD, Agache I, Akdis M, Nadeau K, Klimek L, Jutel M, Akdis CA. The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19. Int Immunol 2021:dxab107. [PMID: 34788827 DOI: 10.1093/intimm/dxab107] [Reference Citation Analysis]
5 Mohseni Afshar Z, Babazadeh A, Hasanpour A, Barary M, Sayad B, Janbakhsh A, Aryanian Z, Ebrahimpour S. Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge. J Med Virol 2021;93:5756-67. [PMID: 34241899 DOI: 10.1002/jmv.27187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Pfaar O, Klimek L, Jutel M, Akdis CA, Bousquet J, Breiteneder H, Chinthrajah S, Diamant Z, Eiwegger T, Fokkens WJ, Fritsch HW, Nadeau KC, O'Hehir RE, O'Mahony L, Rief W, Sampath V, Schedlowski M, Torres MJ, Traidl-Hoffmann C, Wang Y, Zhang L, Bonini M, Brehler R, Brough HA, Chivato T, Del Giacco SR, Dramburg S, Gawlik R, Gelincik A, Hoffmann-Sommergruber K, Hox V, Knol EF, Lauerma A, Matricardi PM, Mortz CG, Ollert M, Palomares O, Riggioni C, Schwarze J, Skypala I, Untersmayr E, Walusiak-Skorupa J, Ansotegui IJ, Bachert C, Bedbrook A, Bosnic-Anticevich S, Brussino L, Canonica GW, Cardona V, Carreiro-Martins P, Cruz AA, Czarlewski W, Fonseca JA, Gotua M, Haahtela T, Ivancevich JC, Kuna P, Kvedariene V, Larenas-Linnemann DE, Abdul Latiff AH, Mäkelä M, Morais-Almeida M, Mullol J, Naclerio R, Ohta K, Okamoto Y, Onorato GL, Papadopoulos NG, Patella V, Regateiro FS, Samoliński B, Suppli Ulrik C, Toppila-Salmi S, Valiulis A, Ventura MT, Yorgancioglu A, Zuberbier T, Agache I. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper. Allergy 2021;76:648-76. [PMID: 32531110 DOI: 10.1111/all.14453] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 43.0] [Reference Citation Analysis]
7 Tanno LK, Demoly P, Martin B, Berstein J, Morais-Almeida M, Levin M, Fiocchi A, Sánchez-Borges M, Caraballo LR, Wong G, Ortega-Martell JA, Rouadi P, Yáñez A, Wang LL, Peden DB, Chikhladze M, González-Díaz SN, Fontaine JF, Sublett J, Chang YS, Passalacqua G, Ansotegui IJ, Ebisawa M, Senna G, Caminati M. Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic. World Allergy Organ J 2021;14:100515. [PMID: 33552380 DOI: 10.1016/j.waojou.2021.100515] [Reference Citation Analysis]
8 Klimek L, Worm M, Lange L, Beyer K, Rietschel E, Vogelberg C, Schnadt S, Stöcker B, Brockow K, Hagemann J, Bieber T, Wehrmann W, Becker S, Freudelsperger L, Mülleneisen NK, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Dramburg S, Matricardi P, Hamelmann E, Werfel T, Wagenmann M, Taube C, Zuberbier T, Ring J. Management von Anaphylaxie-gefährdeten Patienten während der Covid-19-Pandemie: Ein Positionspapier des Ärzteverbandes Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C und des Deutschen Allergie- und Asthmabundes (DAAB)D. Allergo J 2020;29:16-26. [PMID: 33162681 DOI: 10.1007/s15007-020-2618-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
9 Izquierdo-Domínguez A, Rojas-Lechuga MJ, Alobid I. Management of Allergic Diseases During COVID-19 Outbreak. Curr Allergy Asthma Rep 2021;21:8. [PMID: 33560451 DOI: 10.1007/s11882-021-00989-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Stingeni L, Francisci D, Bianchi L, Hansel K, Tramontana M, Di Candilo F, Mannarino MR, Pirro M. Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test. Contact Dermatitis 2021;85:366-8. [PMID: 33834491 DOI: 10.1111/cod.13857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Torres MJ. The complexity of drug hypersensitivity reactions. Allergy 2021;76:985-7. [PMID: 32780432 DOI: 10.1111/all.14555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tomsitz D, Biedermann T, Brockow K. Skin manifestations reported in association with COVID-19 infection. J Dtsch Dermatol Ges 2021;19:530-4. [PMID: 33377313 DOI: 10.1111/ddg.14353] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Pfaar O, Torres MJ, Akdis CA. COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients. Allergy 2021;76:622-5. [PMID: 32589296 DOI: 10.1111/all.14472] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
14 Tomsitz D, Biedermann T, Brockow K. Im Zusammenhang mit COVID-19-Infektionen beschriebene Hautmanifestationen. J Dtsch Dermatol Ges 2021;19:530-5. [PMID: 33861006 DOI: 10.1111/ddg.14353_g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Farmani AR, Mahdavinezhad F, Moslemi R, Mehrabi Z, Noori A, Kouhestani M, Noroozi Z, Ai J, Rezaei N. Anti-IgE monoclonal antibodies as potential treatment in COVID-19. Immunopharmacol Immunotoxicol 2021;43:259-64. [PMID: 34018464 DOI: 10.1080/08923973.2021.1925906] [Cited by in F6Publishing: 2] [Reference Citation Analysis]